Mostrar el registro sencillo del ítem
dc.contributor.author | Martínez Plaza, Elena | |
dc.contributor.author | Molina Martín, Ainhoa | |
dc.contributor.author | Piñero, David P. | |
dc.date.accessioned | 2023-11-22T13:25:15Z | |
dc.date.available | 2023-11-22T13:25:15Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | Applied Sciences, 2022, Vol. 12, Nº. 9, 4589 | es |
dc.identifier.issn | 2076-3417 | es |
dc.identifier.uri | https://uvadoc.uva.es/handle/10324/63159 | |
dc.description | Producción Científica | es |
dc.description.abstract | The goal of this study was to analyze the agreement between the Medmont E300 and the Visionix VX120+ systems in terms of non-invasive tear break-up time (NIBUT) and tear meniscus height (TMH) measurements. A total of 60 eyes (30 healthy subjects) were enrolled. NIBUT and TMH were evaluated with Medmont E300; first NIBUT, NIBUT50%, and TMH were evaluated with Visionix VX120+. Both evaluations were performed in a random order by the same clinician for right, left, and both eyes. The Medmont E300 provided significantly higher NIBUT than Visionix VX120+ for first NIBUT in right, left, and both eyes (p ≤ 0.003) and NIBUT50% in left and both eyes (p ≤ 0.042). The TMH measured with VX120+ was significantly higher than with Medmont E300 considering both eyes (p = 0.037). No significant correlations were found between both devices for either NIBUT (p ≥ 0.11) or TMH (p ≥ 0.09). Passing–Bablok regression analyses revealed poor agreement between devices for NIBUT and TMH outcomes. VX120+ is expected to provide substantial lower first NIBUT values than the NIBUT measured by Medmont E300. Clinicians should consider not using both instruments as interchangeable for dry eye diagnosis. | es |
dc.format.mimetype | application/pdf | es |
dc.language.iso | eng | es |
dc.publisher | MDPI | es |
dc.rights.accessRights | info:eu-repo/semantics/openAccess | es |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject | Eye - Diseases - Treatment | es |
dc.subject | Ojo - Enfermedades y defectos - Tratamiento | es |
dc.subject | Dry eye syndromes | es |
dc.subject | Síndrome de ojo seco | es |
dc.subject | Ophthalmology | es |
dc.subject | Materials science | es |
dc.subject | Ciencia de los materiales | |
dc.subject | Medical technology | |
dc.title | Agreement of tear break-up time and meniscus height between Medmont E300 and Visionix VX120+ | es |
dc.type | info:eu-repo/semantics/article | es |
dc.rights.holder | © 2022 The Authors | es |
dc.identifier.doi | 10.3390/app12094589 | es |
dc.relation.publisherversion | https://www.mdpi.com/2076-3417/12/9/4589 | es |
dc.identifier.publicationfirstpage | 4589 | es |
dc.identifier.publicationissue | 9 | es |
dc.identifier.publicationtitle | Applied Sciences | es |
dc.identifier.publicationvolume | 12 | es |
dc.peerreviewed | SI | es |
dc.description.project | Ministerio de Economía, Industria y Competitividad - (project RYC-2016-20471) | es |
dc.identifier.essn | 2076-3417 | es |
dc.rights | Atribución 4.0 Internacional | * |
dc.type.hasVersion | info:eu-repo/semantics/publishedVersion | es |
dc.subject.unesco | 32 Ciencias Médicas | es |
dc.subject.unesco | 3201.09 Oftalmología | es |
dc.subject.unesco | 3314 Tecnología Médica | es |
Ficheros en el ítem
Este ítem aparece en la(s) siguiente(s) colección(ones)
La licencia del ítem se describe como Atribución 4.0 Internacional